orforglipron semaglutide comparison New GLP pill, orforglipron, versus established GLP pill, in those with obesity & type 2 diabetes. 1️⃣Average blood sugar improved slightly more with (reduced HbA1c by 2.2% from baseline 8.3%) obesity #diabetes #endocrinology #glp1 #obesitytreatment

Vitamins E & C, Selenium, and L-Glutathione provide antioxidant support to promote free-radical-scavenging activities

Tirzepatide is a lab-made peptide used in controlled studies of how cells respond to two related signals, GIP and GLP-1

Patients should be alert to: Persistent constipation , which may increase diverticular pressure New or worsening abdominal pain , especially if localised to the lower abdomen Changes in stool consistency or frequency Fever or systemic symptoms suggesting infection Communication with healthcare providers is vital

For compounded tirzepatide in vials, the stability window is typically shorter

Abstract Background Although therapeutic options for inflammatory bowel disease (IBD) have advanced, many patients still experience suboptimal clinical response, systemic side effects, or difficulty maintaining long-term treatment adherence